Adjuvant dendritic cell-based tumour vaccination for children with malignant brain tumours. Oct 2009 - Pediatr Blood Cancer:1545-5017 [PMID:19852061] [Ardon H] [De Vleeschouwer S] [Van Calenbergh F] [Claes L] [Kramm CM] [Rutkowski S] [Wolff JE] [Van Gool SW]
Postoperative adjuvant dendritic cell-based immunotherapy in patients with relapsed glioblastoma multiforme. May 2008 - Clin. Cancer Res.; 14(10):1078-0432 [PMID:18483377] [De Vleeschouwer S] [Fieuws S] [Rutkowski S] [Van Calenbergh F] [Van Loon J] [Goffin J] [Sciot R] [Wilms G] [Demaerel P] [Warmuth-Metz M] [Soerensen N] [Wolff JE] [Wagner S] [Kaempgen E] [Van Gool SW]
Surgery and adjuvant dendritic cell-based tumour vaccination for patients with relapsed malignant glioma, a feasibility study. Oct 2004 - Br. J. Cancer; 91(9):0007-0920 [PMID:15477864] [Rutkowski S] [De Vleeschouwer S] [Kaempgen E] [Wolff JE] [Kühl J] [Demaerel P] [Warmuth-Metz M] [Flamen P] [Van Calenbergh F] [Plets C] [Sörensen N] [Opitz A] [Van Gool SW]
Transient local response and persistent tumor control in a child with recurrent malignant glioma: treatment with combination therapy including dendritic cell therapy. Case report. Aug 2004 - J. Neurosurg.; 100(5 Suppl Pediatrics):0022-3085 [PMID:15287461] [De Vleeschouwer S] [Van Calenbergh F] [Demaerel P] [Flamen P] [Rutkowski S] [Kaempgen E] [Wolff JE] [Plets C] [Sciot R] [Van Gool SW]
